US FDA proposes curbs on mass compounding of Novo, Lilly’s weight-loss drugs – Reuters By Weight Loss US FDA proposes curbs on mass compounding of Novo, Lilly’s weight-loss drugs Reuters Brought to you by Google News. Read the rest of the article here Facebook Twitter Pinterest